MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Renalytix AI forms kidney health partnership with University of Utah

StockMarketWire.com

Kidney disease diagnostics group Renalytix AI said it had formed a partnership with the University of Utah to improve kidney health for large-scale populations.

The partnership intended to implement RenalytixAI's in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions to optimize patient care.

KidneyIntelX qas designed for the identification of adults with early-stage chronic kidney disease and diabetes at risk for progressive kidney function decline or kidney failure.

'Core to this partnership is the implementation of care navigation and pharmacy programs, behavioral and health economic assessments, together with data-driven analytics,' the company said.

KidneyIntelX would be deployed directly into the electronic health records system at University of Utah Health, enabling access to more than 1,700 clinicians.



Story provided by StockMarketWire.com